Gabelli & Co Investment Advisers’s CVS Health CVS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	+2,500	New	+$223K	0.04%	231
2024 Q1	–	Sell	-3,000	Closed	-$237K	–	264
2023 Q4	$237K	Hold	3,000	–	–	0.04%	165
2023 Q3	$209K	Hold	3,000	–	–	0.03%	177
2023 Q2	$207K	Hold	3,000	–	–	0.03%	175
2023 Q1	$223K	Hold	3,000	–	–	0.04%	146
2022 Q4	$280K	Hold	3,000	–	–	0.06%	160
2022 Q3	$286K	Hold	3,000	–	–	0.04%	265
2022 Q2	$278K	Hold	3,000	–	–	0.04%	287
2022 Q1	$304K	Hold	3,000	–	–	0.04%	287
2021 Q4	$309K	Sell	3,000 -116	-4%	-$10.7K	0.04%	293
2021 Q3	$264K	Hold	3,116	–	–	0.03%	296
2021 Q2	$260K	Sell	3,116 -1,534	-33%	-$126K	0.03%	286
2021 Q1	$350K	Buy	4,650 +1,000	+27%	+$72.8K	0.04%	261
2020 Q4	$249K	Buy	3,650 +150	+4%	+$9.76K	0.04%	233
2020 Q3	$204K	Hold	3,500	–	–	0.04%	180
2020 Q2	$227K	Hold	3,500	–	–	0.05%	144
2020 Q1	$208K	Buy	3,500 +500	+17%	+$33.4K	0.03%	144
2019 Q4	$223K	Buy	+3,000	New	+$211K	0.03%	157
2016 Q4	–	Sell	-3,000	Closed	-$267K	–	156
2016 Q3	$267K	Hold	3,000	–	–	0.03%	135
2016 Q2	$287K	Hold	3,000	–	–	0.04%	141
2016 Q1	$311K	Hold	3,000	–	–	0.04%	130
2015 Q4	$293K	Hold	3,000	–	–	0.03%	144
2015 Q3	$289K	Buy	3,000 +500	+20%	+$52.6K	0.04%	137
2015 Q2	$262K	Buy	+2,500	New	+$255K	0.04%	142

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gabelli & Co Investment Advisers's CVS Position: Q2 2026 in Review

Gabelli & Co Investment Advisers opened a new position in CVS Health (CVS) in Q2 2026: 2,500 shares worth $259K. The stake represents 0.04% of the portfolio and ranks #231 among its holdings. This is a return to the name: Gabelli & Co Investment Advisers previously reported a position in CVS as recently as Q4 2023.

Gabelli & Co Investment Advisers first reported a position in CVS in Q2 2015 and has held it in 24 quarters since. The position peaked at $350K in Q1 2021. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Gabelli & Co Investment Advisers held 2,500 shares of CVS Health worth $259K as of Q2 2026.
CVS Health was a new Gabelli & Co Investment Advisers position in Q2 2026.
CVS Health made up 0.04% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #231 holding.
Gabelli & Co Investment Advisers first reported a position in CVS Health in Q2 2015 and has held it in 24 quarters since.
Gabelli & Co Investment Advisers's CVS Health position peaked at $350K in Q1 2021.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.